Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO
暂无分享,去创建一个
N. Hosten | S. Endres | R. Ladenstein | A. Garaventa | P. Brock | H. Lode | D. Valteau‐Couanet | W. Barthlen | N. Siebert | H. Loibner | E. Janzek | K. Ehlert | S. Kietz | Ina Mueller | A. Zinke | Emine Varol | L. Pill